{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:39:13Z","timestamp":1790246353198,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.urolonc.2019.10.008","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T09:25:53Z","timestamp":1575451553000},"page":"37.e1-37.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsy"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-6256","authenticated-orcid":false,"given":"Ting-Shuai","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimaitiaji","family":"Kadier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Dong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2019.10.008_bib0001","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0002","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0003","doi-asserted-by":"crossref","first-page":"djv436","DOI":"10.1093\/jnci\/djv436","article-title":"Presentation of benefits and harms in US cancer screening and prevention guidelines: systematic review","volume":"108","author":"Caverly","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0004","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.eururo.2007.03.054","article-title":"Obesity and prostate cancer: a role for adipokines","volume":"52","author":"Mistry","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0006","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0007","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1038\/ncomms10230","article-title":"Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity","volume":"7","author":"Laurent","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0008","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/pcan.2017.31","article-title":"Periprostatic adipose inflammation is associated with high-grade prostate cancer","volume":"20","author":"Gucalp","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0009","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/pros.22756","article-title":"Periprostatic adipose tissue from obese prostate cancer patients promotes tumor and endothelial cell proliferation: a functional and MR imaging pilot study","volume":"74","author":"Venkatasubramanian","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2214\/AJR.14.12689","article-title":"Periprostatic fat thickness on MRI: correlation with Gleason Score in prostate cancer","volume":"204","author":"Sungmin","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0011","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging \u2013 reporting and data system: 2015, Version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0012","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.euf.2017.01.019","article-title":"Peri-prostatic fat volume measurement as a predictive tool for castration resistance in advanced prostate cancer","volume":"4","author":"Salji","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0013","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"29","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0014","series-title":"Primer of applied regression and analysis of variance","author":"Glantz","year":"1990"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.eururo.2009.08.025","article-title":"A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer","volume":"57","author":"Roobolbouts","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0016","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.juro.2016.03.011","article-title":"Serial percent-free PSA in combination with PSA for population-based early detection of prostate cancer","volume":"196","author":"Ankerst","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0017","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pros.22561","article-title":"Prostate health index (PHI) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy","volume":"73","author":"Perdon\u00e0","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0018","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0019","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0020","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1464-410X.2012.10957.x","article-title":"Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer","volume":"110","author":"Bhindi","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0021","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.urology.2016.07.042","article-title":"Periprostatic fat: a risk factor for prostate cancer?","volume":"98","author":"Tan","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0022","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/bju.14469","article-title":"Periprostatic fat adipokines expression correlated with prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease","volume":"123","author":"Naief","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0023","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrendo.2014.94","article-title":"Obesity and cancer \u2013 mechanisms underlying tumour progression and recurrence","volume":"10","author":"Park","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0024","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/cncr.22534","article-title":"Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men","volume":"109","author":"Gong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/aja.2013.104","article-title":"Influence of obesity on localized prostate cancer patients treated with radical prostatectomy","volume":"15","author":"Qu","year":"2013","journal-title":"Asian J Androl"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0026","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/bju.12600","article-title":"Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea","volume":"114","author":"Park","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0027","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","article-title":"Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring","volume":"291","author":"Lloyd-Jones","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0028","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1158\/1055-9965.EPI-11-1017","article-title":"Prostate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE study","volume":"21","author":"Thomas","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0029","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.2010.31.5200","article-title":"Total cholesterol and cancer risk in a large prospective study in Korea","volume":"29","author":"Kitahara","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/pcan.2012.54","article-title":"Association between metabolic syndrome, diabetes mellitus and prostate cancer risk","volume":"16","author":"Lawrence","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2019.10.008_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2016.04.004","article-title":"Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy","volume":"34","author":"Chen","year":"2016","journal-title":"Urol Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919304144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919304144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:17:15Z","timestamp":1761041835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143919304144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1078143919304144"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.10.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}